BBI Group Acquires DIARECT AG
June 3, 2020
BBI Group has acquired DIARECT AG, a Freiburg-based supplier of recombinant autoimmune antigen products, integrating DIARECT's manufacturing facility to establish a centre of excellence for recombinant antigen development. The deal expands BBI's immunoassay reagent portfolio and capabilities, enabling the combined company to pursue high-growth disease segments and broaden DIARECT's geographic reach through BBI's larger sales organization.
- Buyers
- BBI Group
- Targets
- DIARECT AG
- Industry
- Medical Devices
- Location
- Baden-Württemberg, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Anteo Diagnostics Acquires DIAsource ImmunoAssays SA
August 26, 2015
Medical Devices
Anteo Diagnostics will acquire 100% of DIAsource ImmunoAssays SA for EUR15.4m (with a two-year vendor earn-out), expanding Anteo's product range, manufacturing capabilities and global distribution. DIAsource, headquartered in Louvain-la-Neuve, Belgium, reported EUR11.9m revenue in 2014 (EUR7.2m in H1 2015) and the combined business will total about 100 personnel; the deal is subject to financing and regulatory approvals.
-
BBI Solutions Acquires IBEX Technologies Inc.
April 8, 2024
Biotechnology
BBI Solutions OEM Limited has acquired IBEX Technologies Inc., a Montreal-based developer and manufacturer of high-precision enzymes and diagnostic solutions, with the transaction closing on April 8, 2024. The acquisition expands BBI's recombinant protein and enzyme capabilities to better serve in-vitro diagnostics (IVD) manufacturers and brings IBEX's staff and contract-manufacturing capabilities into BBI's global operations.
-
BioCheck, Inc. Acquires DRG International, Inc.
August 18, 2021
Medical Devices
BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.
-
R-Biopharm AG Acquires AusDiagnostics
June 7, 2022
Biotechnology
German biotechnology company R-Biopharm AG has acquired Australian molecular diagnostics manufacturer AusDiagnostics. The purchase adds AusDiagnostics' multiplex MT-PCR platforms, extraction reagents and laboratory automation capabilities to R-Biopharm's clinical diagnostics portfolio, supporting capability expansion and internationalization into new clinical, veterinary and applied testing markets.
-
Novo Holdings Acquires BBI Group
June 15, 2021
Medical Devices
Novo Holdings A/S has agreed to acquire BBI Group from Exponent for an enterprise value of over GBP 400 million, becoming the company's majority shareholder. BBI, a Crumlin, South Wales–headquartered supplier of diagnostics reagents, lateral flow development and diagnostic manufacturing services with more than 400 employees, will benefit from Novo Holdings' life-sciences expertise to pursue organic and inorganic growth.
-
Calibre Scientific Acquires Dianova GmbH
October 27, 2020
Biotechnology
Calibre Scientific announced the acquisition of Dianova GmbH, a Hamburg-based manufacturer and distributor of antibodies, immunoassays and molecular biology products. Dianova will be integrated into BIOZOL Diagnostica GmbH (a Calibre Scientific subsidiary) to expand product offerings and strengthen distribution across the DACH region (Germany, Austria, Switzerland).
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.